Delivery Order SPE2DE24D0014-SPE2D625F0YMB
- Not listed
- The U.S. Department of Defense Medical Supply Chain awarded a fixed-price delivery order with economic price adjustment to Government Scientific Source Inc. on June 4, 2025, with a ceiling value of $1,545.33 for the procurement of FBS Characterized US 500 ML (fetal bovine serum). The contract, which is scheduled for completion by June 26, 2025, will be performed in Herndon, Virginia. This delivery order was issued without a set-aside designation and represents a continuation of the...
- The U.S. Defense Department's Medical Supply Chain awarded a $2,015.84 fixed-price delivery order to Government Scientific Source Inc., a small business laboratory supplier based in Reston, Virginia, for FBS (fetal bovine serum) characterized at 500 milliliters. The award was issued on September 12, 2025, with an ultimate completion date of October 3, 2025, and will be performed in Herndon, Virginia. This delivery order was not set aside for any specific business category and represents a...
- The U.S. Defense Medical Supply Chain awarded a $15,453.30 delivery order to Government Scientific Source Inc., a small business located in Reston, Virginia, for HyClone fetal bovine serum (FBS) 500ml sterile product. Issued on June 10, 2025, with an ultimate completion date of July 2, 2025, this fixed-price delivery order with economic price adjustment is being performed in Herndon, Virginia. The award carries no set-aside designation. Government Scientific Source Inc. (UEI: J49CN39QTNW3) is an...
- Government Scientific Source Inc., a small business specializing in laboratory products and scientific equipment, was awarded a delivery order valued at $7,245.46 by the Medical Supply Chain, a defense-oriented federal agency. The contract, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, is for the procurement of 500 mL of characterized FBS (fetal bovine serum), a critical reagent used in cell culture and biological research applications. The award utilizes a...
- The U.S. Department of Defense Medical Supply Chain awarded a fixed-price delivery order valued at $2,060.44 to Government Scientific Source Inc., a small business headquartered in Reston, Virginia, for the procurement of 500 milliliters of characterized fluorescent brightening substance (FBS). The order, issued on April 24, 2025, with an ultimate completion date of May 15, 2025, will be performed at the contractor's facility in Herndon, Virginia. This delivery order was issued without a small...
- Government Scientific Source Inc., a small business based in Reston, Virginia, has been awarded a $3,023.76 delivery order for 500 milliliters of characterized fluorescein-labeled bovine serum albumin (FBS) by the Defense Department's Medical Supply Chain. The contract, awarded on August 8, 2025, with an ultimate completion date of August 29, 2025, utilizes a fixed-price pricing structure with economic price adjustment provisions and carries no set-aside designation. The place of performance...
- The U.S. government agency, identified as the Medical Supply Chain, has awarded a $24,862.80 fixed-price delivery order contract to Government Scientific Source Inc., a for-profit organization, to provide 4,566,621,064 units of FBS CHARACTERIZED US HI 500 ML. This order is not designated as a set-aside contract. Government Scientific Source Inc. is a leading distributor of laboratory products and equipment, providing a variety of scientific products and services as a prime contractor,...
- This is a $24,725.28 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Government Scientific Source Inc., a for-profit organization and federal contractor specializing in laboratory products and equipment. The contract is for the supply of 4567835429 FBS CHARACTERIZED US 500 ML, a type of laboratory product, with a period of performance through April 28, 2025. Government Scientific Source Inc. is a registered vendor in the System for Award Management (SAM)...
- This is a $2,812.50 fixed-price delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency to Government Scientific Source Inc., a for-profit organization that specializes in distributing laboratory products and equipment to federal agencies. The award is for 4565390386 FBS CHARACTERIZED US 500 ML, with an ultimate completion date of August 29, 2024. This delivery order is part of a larger contract vehicle, and the vendor has previously provided a variety of...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to Government Scientific Source Inc., a for-profit organization and leading distributor of laboratory products and equipment, for the purchase of 4564836129 FBS CHARACTERIZED US HI 500 ML. The $4,837.50 fixed-price with economic price adjustment contract has a completion date of July 1, 2024 and does not include a set-aside designation. Government Scientific Source Inc. has a history of providing a variety of scientific...
- SPE2DE24D0014Indefinite Delivery Contract
- SPE2DE24D0014-SPE2D625F0YMBDelivery Order
The U.S. Department of Defense's Medical Supply Chain awarded a $3,527.72 fixed-price delivery order to Government Scientific Source Inc. for 500 milliliters of characterized FBS (fetal bovine serum) on August 13, 2025, with an ultimate completion date of September 4, 2025. The contract does not carry a set-aside designation. Government Scientific Source Inc., a small business headquartered in Reston, Virginia, and registered with the System for Award Management since March 2002, specializes in providing laboratory products, scientific equipment, and diagnostic testing materials to federal agencies through the General Services Administration's Multiple Award Schedule contract vehicle. This delivery order represents part of the broader procurement activities through which Government Scientific Source Inc. supplies critical scientific and medical research consumables to defense and civilian agencies. The FBS procurement supports the Medical Supply Chain's laboratory and research operations, likely for cell culture and other biomedical applications. The fixed-price structure with economic price adjustment provides cost predictability while allowing for adjustments based on market conditions. The relatively short performance window of approximately three weeks reflects the nature of this specific consumable supply delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 8/13/25 |